Trulieve posts Q3 and nine‑month 2025 results, investor deck

Rhea-AI Filing Summary

Trulieve Cannabis Corp. furnished an update on its business. The company announced its results for the three and nine months ended September 30, 2025 via a press release and provided an investor slide deck for conference use. Both materials are dated November 5, 2025 and were submitted as Exhibits 99.1 and 99.2. The company noted these materials are furnished, not filed, and therefore are not subject to Section 18 liability.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false000175419500017541952025-11-052025-11-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________

FORM 8-K

___________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 5, 2025

___________________

TRULIEVE CANNABIS CORP.

(Exact Name of Registrant as specified in its charter)

___________________

British Columbia			000-56248			84-2231905
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(IRS Employer Identification No.)

6749 Ben Bostic Road
Quincy, FL 32351
(Address of principal executive offices and zip code)

(850) 298-8866

(Registrant’s telephone number, including area code)

Not Applicable

(Registrant’s name or former address, if change since last report)

___________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. o

Item 2.02    Results of Operations and Financial Condition.

On November 5, 2025, Trulieve Cannabis Corp. (the “Company”) announced via press release its results for the three and nine months ended September 30, 2025. A copy of the Company’s press release is hereby furnished to the Commission and incorporated herein by reference as Exhibit 99.1.

Item 7.01    Regulation FD Disclosure.

The Company from time to time presents at various industry and other conferences and provides summary business information. A copy of the slide presentation that will be used by representatives of the Company in connection with such presentations (the “Corporate Presentation”) is attached to this Current Report on Form 8-K as Exhibit 99.2. The Corporate Presentation is current as of November 5, 2025, and the Company disclaims any obligation to correct or update this material in the future.

Item 9.01.    Financial Statements and Exhibits.

(d)Exhibits

Exhibit No.						Description
99.1*						Press release dated November 5, 2025
99.2*						Corporate Presentation dated November 5, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

*The information in the press release attached as Exhibit 99.1 and the corporate presentation attached as Exhibit 99.2 is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Trulieve Cannabis Corp.
			By:			/s/ Eric Powers
			Name:			Eric Powers
			Title:			Chief Legal Officer

Date: November 5, 2025

FAQ

What did Trulieve (TCNNF) announce in this 8-K?

Results for the three and nine months ended September 30, 2025, shared via a press release.

Which exhibits were included with Trulieve’s filing?

Exhibit 99.1: press release dated November 5, 2025; Exhibit 99.2: corporate presentation dated November 5, 2025.

Are the Trulieve materials filed or furnished?

They are furnished, not filed, and are not subject to Section 18 of the Exchange Act.

What period does Trulieve’s update cover?

The three and nine months ended September 30, 2025.

What is the purpose of the corporate presentation?

It is used at industry and other conferences and provides summary business information.

When are the Trulieve materials current as of?

They are current as of November 5, 2025.